{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:46:34Z","timestamp":1787859994160,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["HICG\/1\/14"],"award-info":[{"award-number":["HICG\/1\/14"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s40266-018-0560-4","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T22:26:41Z","timestamp":1529360801000},"page":"657-663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials"],"prefix":"10.1007","volume":"35","author":[{"given":"Jennifer K.","family":"Burton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Papworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Haig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"McCowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Stott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-0181","authenticated-orcid":false,"given":"Terence J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"issue":"15","key":"560_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa065994","volume":"357","author":"I Ford","year":"2007","unstructured":"Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357(15):1477\u201386.","journal-title":"N Engl J Med."},{"key":"560_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/LPI.S37450","volume":"9","author":"JT Davies","year":"2016","unstructured":"Davies JT, Delfino SF, Feinberg CE, et al. Current and emerging uses of statins in clinical therapeutics: a review. Lipid Insights. 2016;9:13\u201329.","journal-title":"Lipid Insights."},{"key":"560_CR3","doi-asserted-by":"crossref","unstructured":"McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;(1):CD003160.","DOI":"10.1002\/14651858.CD003160.pub3"},{"issue":"9","key":"560_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/qjmed\/hcp093","volume":"102","author":"D Scott","year":"2009","unstructured":"Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009;102(9):625\u201333.","journal-title":"QJM."},{"key":"560_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/bmj.320.7231.341","volume":"320","author":"G Salkeld","year":"2000","unstructured":"Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ. 2000;320:241\u20136.","journal-title":"BMJ."},{"key":"560_CR6","doi-asserted-by":"publisher","first-page":"d4681","DOI":"10.1136\/bmj.d4681","volume":"343","author":"TJ Quinn","year":"2011","unstructured":"Quinn TJ, McArthur K, Ellis G, Stott DJ. Functional assessment in older people. BMJ. 2011;343:d4681.","journal-title":"BMJ."},{"key":"560_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamainternmed.2016.4362","volume":"176","author":"EB Rubin","year":"2016","unstructured":"Rubin EB, Buehler AE, Halpern SD. States worse than death among hospitalized patients with serious illnesses. JAMA Intern Med. 2016;176:1557\u20139.","journal-title":"JAMA Intern Med."},{"issue":"Suppl 2","key":"560_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ageing\/26.suppl_2.3","volume":"26","author":"MW Ribbe","year":"1997","unstructured":"Ribbe MW, Ljunggren G, Steel K, et al. Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing. 1997;26(Suppl 2):3\u201312.","journal-title":"Age Ageing."},{"issue":"20","key":"560_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","volume":"333","author":"J Shepherd","year":"1995","unstructured":"Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301\u20137.","journal-title":"N Engl J Med."},{"issue":"9346","key":"560_CR10","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","volume":"360","author":"J Shepherd","year":"2002","unstructured":"Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623\u201330.","journal-title":"Lancet."},{"key":"560_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0002-9149(99)80135-0","volume":"76","author":"WOSCOPS Study Group","year":"1995","unstructured":"WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol. 1995;76:485\u201391.","journal-title":"Am J Cardiol."},{"key":"560_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1468-6708-3-8","volume":"3","author":"I Ford","year":"2002","unstructured":"Ford I, Blauw GJ, Murphy MB, et al. A prospective study of pravastatin in the elderly at risk (PROSPER) screening experience and baseline characteristics. Curr Control Trials Cardiovasc Med. 2002;3:8.","journal-title":"Curr Control Trials Cardiovasc Med."},{"issue":"11","key":"560_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.115.019014","volume":"133","author":"I Ford","year":"2016","unstructured":"Ford I, Murray H, McCowan C, Packard CJ. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study. Circulation. 2016;133(11):1073\u201380.","journal-title":"Circulation."},{"issue":"8","key":"560_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/0895-4356(92)90068-X","volume":"45","author":"The West of Scotland Coronary Prevention Study Group","year":"1992","unstructured":"The West of Scotland Coronary Prevention Study Group. A coronary primary prevention study of Scottish men aged 45\u201364\u00a0years: trial design. J Clin Epidemiol. 1992;45(8):849\u201360.","journal-title":"J Clin Epidemiol."},{"issue":"10","key":"560_CR15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","volume":"84","author":"J Shepherd","year":"1999","unstructured":"Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol. 1999;84(10):1192\u20137.","journal-title":"Am J Cardiol."},{"issue":"4","key":"560_CR16","first-page":"162","volume":"48","author":"V Carstairs","year":"1990","unstructured":"Carstairs V, Morris R. Deprivation and health in Scotland. Health Bull (Edinb). 1990;48(4):162\u201375.","journal-title":"Health Bull (Edinb)."},{"issue":"6967","key":"560_CR17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/bmj.309.6967.1465","volume":"309","author":"P McLoone","year":"1994","unstructured":"McLoone P, Boddy FA. Deprivation and mortality in Scotland, 1981 and 1991. BMJ. 1994;309(6967):1465\u201370.","journal-title":"BMJ."},{"issue":"9","key":"560_CR18","doi-asserted-by":"publisher","first-page":"e75379","DOI":"10.1371\/journal.pone.0075379","volume":"8","author":"SJ Barry","year":"2013","unstructured":"Barry SJ, Dinnett E, Kean S, et al. Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention Study. PLoS One. 2013;8(9):e75379.","journal-title":"PLoS One."},{"issue":"3","key":"560_CR19","doi-asserted-by":"publisher","first-page":"e002333","DOI":"10.1136\/bmjopen-2012-002333","volume":"3","author":"D Gnjidic","year":"2013","unstructured":"Gnjidic D, Le Couteur DG, Blyth FM, et al. Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open. 2013;3(3):e002333.","journal-title":"BMJ Open."},{"issue":"3","key":"560_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2190\/AG.74.3.b","volume":"74","author":"R Pruchno","year":"2012","unstructured":"Pruchno R, Hahn S, Wilson-Genderson M. Cigarette smokers, never-smokers, and transitions: implications for successful aging. Int J Aging Hum Dev. 2012;74(3):193\u2013209.","journal-title":"Int J Aging Hum Dev."},{"issue":"4","key":"560_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/ageing\/afx047","volume":"46","author":"JK Harrison","year":"2017","unstructured":"Harrison JK, Walesby KE, Hamilton L, et al. Predicting discharge to institutional long-term care following acute hospitalisation: a systematic review and meta-analysis. Age Ageing. 2017;46(4):547\u201358.","journal-title":"Age Ageing."},{"issue":"1","key":"560_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ageing\/afp202","volume":"39","author":"M Luppa","year":"2010","unstructured":"Luppa M, Luck T, Weyerer S, et al. Prediction of institutionalization in the elderly. A systematic review. Age Ageing. 2010;39(1):31\u20138.","journal-title":"Age Ageing."},{"issue":"1","key":"560_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12883-017-0841-2","volume":"17","author":"FN Doubal","year":"2017","unstructured":"Doubal FN, Ali M, Batty GD, et al. Big data and data repurposing: using existing data to answer new questions in vascular dementia research. BMC Neurol. 2017;17(1):72.","journal-title":"BMC Neurol."},{"key":"560_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejim.2017.12.011","volume":"50","author":"M Ruscica","year":"2018","unstructured":"Ruscica M, Macchi C, Pavanelo C, Corsini A, Sahebkar A, Sirtoni CR. Appropriateness of statin prescription in the ederly. Eur J Intern Med. 2018;50:33\u201340.","journal-title":"Eur J Intern Med."},{"issue":"7","key":"560_CR25","doi-asserted-by":"publisher","first-page":"e008017","DOI":"10.1136\/bmjopen-2015-008017","volume":"5","author":"C Murphy","year":"2015","unstructured":"Murphy C, Bennett K, Fahey T, et al. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA). BMJ Open. 2015;5(7):e008017.","journal-title":"BMJ Open."},{"issue":"9","key":"560_CR26","doi-asserted-by":"publisher","first-page":"e72642","DOI":"10.1371\/journal.pone.0072642","volume":"8","author":"SM Lloyd","year":"2013","unstructured":"Lloyd SM, Stott DJ, de Craen AJ, et al. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One. 2013;8(9):e72642.","journal-title":"PLoS One."},{"key":"560_CR27","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/eurheartj\/ehr333","volume":"32","author":"PS Sever","year":"2011","unstructured":"Sever PS, Chang CL, Gupta AK, et al. The Anglo-Scandinavian Cardiac Outcomes Trial: 11\u00a0year mortality follow-up of the lipid lowering arm in the UK. Eur Heart J. 2011;32:2525\u201332.","journal-title":"Eur Heart J."},{"key":"560_CR28","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.117.028271","volume":"135","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary prevention with statin therapy in the elderly. Circulaton. 2017;135:1979\u201381.","journal-title":"Circulaton."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-018-0560-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T18:48:53Z","timestamp":1661453333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-018-0560-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s40266-018-0560-4","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"19 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was supported by the NHS Scotland, Chief Scientist Office (HICG\/1\/14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jennifer K. Burton, Richard Papworth, Caroline Haig, Colin McCowan, Ian Ford, and Terence J. Quinn declare that they have no relevant conflicts of interest that may be relevant to this manuscript. David J. Stott received research funding support from Bristol-Myers Squibb for the PROSPER and WOSCOPS studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The sponsors played no part in the design, conduct or analysis of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sponsor\u2019s role"}}]}}